Natalie Lorent
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Tuberculosis Research and Epidemiology 19
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 7
- Epidemiology 26
- Mycobacterium research and diagnosis 13
- Pneumocystis jirovecii pneumonia detection and treatment 8
- Co-authors
- Christophe Dooms (5 shared papers)Johan Vansteenkiste (2 shared papers)Lutgarde Lynen (11 shared papers)Katrien Lagrou (5 shared papers)Sopheak Thai (7 shared papers)Yannick Vande Weygaerde (7 shared papers)Emmanuel André (8 shared papers)Johan van Griensven (5 shared papers)
- Journals
- The International Journal of Tuberculosis and Lung Disease (3 papers)PLoS ONE (3 papers)European Respiratory Journal (2 papers)Journal of Clinical Medicine (2 papers)Journal of Cystic Fibrosis (2 papers)
- Partner nations
- BelgiumUnited KingdomItaly
In The Last Decade
Natalie Lorent
55 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 102
- Infectious Diseases 490
- Pulmonary and Respiratory Medicine 339
- Epidemiology 296
- Critical Care and Intensive Care Medicine 39
- Radiology, Nuclear Medicine and Imaging 158
Countries citing papers authored by Natalie Lorent
This map shows the geographic impact of Natalie Lorent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Lorent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Lorent more than expected).
Fields of papers citing papers by Natalie Lorent
This network shows the impact of papers produced by Natalie Lorent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Lorent. The network helps show where Natalie Lorent may publish in the future.
Co-authors
The 25 scholars most cited alongside Natalie Lorent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 171 | |
| 2 | 2021 | 92 | |
| 3 | 2004 | 90 | |
| 4 | 2014 | 88 | |
| 5 | 2022 | 54 | |
| 6 | 2015 | 42 | |
| 7 | 2011 | 41 | |
| 8 | 2020 | 39 | |
| 9 | 2019 | 35 | |
| 10 | 2017 | 35 | |
| 11 | 2020 | 34 | |
| 12 | 2021 | 32 | |
| 13 | Risk factors for delay in the diagnosis and treatment of tuberculosis at a referral hospital in Rwanda. | 2008 | 30 |
| 14 | 2020 | 29 | |
| 15 | 2017 | 22 | |
| 16 | 2017 | 22 | |
| 17 | 2013 | 17 | |
| 18 | 2018 | 17 | |
| 19 | 2021 | 16 | |
| 20 | 2015 | 15 |
About Natalie Lorent
Natalie Lorent is a scholar working on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Surgery and Neurology, having authored 63 papers that have together received 1.0k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (19 papers), Mycobacterium research and diagnosis (13 papers), Cystic Fibrosis Research Advances (12 papers), Neonatal Respiratory Health Research (9 papers), Long-Term Effects of COVID-19 (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers), COVID-19 Clinical Research Studies (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). The work is most often cited by research in Infectious Diseases (490 citations), Pulmonary and Respiratory Medicine (339 citations), Epidemiology (296 citations), Critical Care and Intensive Care Medicine (39 citations) and Radiology, Nuclear Medicine and Imaging (158 citations). Natalie Lorent has collaborated with scholars based in Belgium, United Kingdom and Italy. Frequent co-authors include Christophe Dooms, Johan Vansteenkiste, Lutgarde Lynen, Katrien Lagrou, Sopheak Thai, Yannick Vande Weygaerde, Emmanuel André, Johan van Griensven, Lieven Dupont and Pieter Vermeersch. Their work appears in journals such as The International Journal of Tuberculosis and Lung Disease, PLoS ONE, European Respiratory Journal, Journal of Clinical Medicine and Journal of Cystic Fibrosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.